Additionally, late-stage cancer cells display altered TGF-β signaling, dampening or negating the growth-inhibitory or apoptosis-inducing effects of TGF-β, which in turn favors the balance towards oncogenic TGF-β signaling. This evidence concerns the gene TGFB1 and cancer.